- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05073198
The Effect of the Brochure on Testicular Self-Exam
September 28, 2021 updated by: BUSRA ALTINEL, Selcuk University
The Effect of the Brochure Given to University Students on Testicular Cancer and Its Early Diagnosis on Health Beliefs and Testicular Self-Examination
This study aims to examine the effect of the educational brochure given to university students on testicular cancer and its early diagnosis on their health beliefs and self-examination; In non-randomized groups, pretest-posttest was conducted in a quasi-experimental design with control group.
The research was carried out with students studying in the psychological counseling and guidance department of a state university in Turkey.
The study group consisted of 92 students, 48 of which were experimental and 44 were control.
Only the experimental group was given an educational brochure about testicular cancer and testicular self-examination.
Data; Personal information form, testicular cancer and health beliefs scale about testicular self-examination were collected with the form for self-examination.
In the evaluation of the data; Mann Whitney U, Wilcoxon and chi-square analyzes were performed.
Study Overview
Study Type
Interventional
Enrollment (Actual)
92
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Selcuklu
-
Konya, Selcuklu, Turkey, 42100
- Selcuk University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- To study in the Department of Psychological Counseling and Guidance
- Studying in 3rd and 4th grade
Exclusion Criteria:
- Any previous diagnosis of cancer
- Having received previous training in Testicular Self Examination
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Control
No intervention
|
|
|
EXPERIMENTAL: Experiment
Giving educational brochures about testicular cancer and Testicular Self-Examination to the students in the experimental group
|
In the content of the brochure about testicular cancer and CCTM prepared in line with the literature; It includes information such as the definition of testicular cancer, testicular cancer risk factors and symptoms, the importance of early diagnosis in testicular cancer, how CCTM is performed, and what to do in case of differences after the examination.
Expert opinion was obtained from three faculty members (a professor from the Department of Urology, a professor in Public Health Nursing and a physician faculty member) regarding the content validity of the educational brochure created before the research.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
rate of testicular self-exam
Time Frame: after 4 weeks
|
After the training brochure given to the students, they are expected to do testicular examination on their own.
|
after 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 5, 2019
Primary Completion (ACTUAL)
July 20, 2020
Study Completion (ACTUAL)
June 16, 2021
Study Registration Dates
First Submitted
September 19, 2021
First Submitted That Met QC Criteria
September 28, 2021
First Posted (ACTUAL)
October 11, 2021
Study Record Updates
Last Update Posted (ACTUAL)
October 11, 2021
Last Update Submitted That Met QC Criteria
September 28, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20202002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Testicular Cancer
-
Haukeland University HospitalKarolinska University Hospital; Oslo University Hospital; University Hospital... and other collaboratorsRecruitingSeminoma | Testicular Germ Cell Cancer | Non-Seminoma Testicular Cancer | Stage I Testicular Cancer | Stage II Testicular Cancer | Stage III Testicular Cancer | Stage IV Testicular Cancer | Relapse Testicular CancerNorway, Sweden
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingSeminoma | Germ Cell Tumor | Metachronous Malignant Neoplasm | Stage I Testicular Cancer AJCC v8 | Stage IA Testicular Cancer AJCC v8 | Stage IB Testicular Cancer AJCC v8 | Stage IS Testicular Cancer AJCC v8Canada, United States, Guam
-
Gustave Roussy, Cancer Campus, Grand ParisNot yet recruitingTestis Cancer | Testicular Cancer | AYA Cancer Survivors | Survivor Patients
-
University Medical Center GroningenDutch Cancer SocietyCompletedNon-seminomatous Testicular CancerNetherlands
-
National Cancer Institute, SlovakiaCompletedTesticular CancerSlovakia
-
University of California, IrvineMemorial Sloan Kettering Cancer CenterUnknown
-
University Hospital, Clermont-FerrandRecruiting
-
University of Texas Southwestern Medical CenterCompletedTesticular Germ Cell Tumor | Testicular Neoplasms | Testicular Diseases | Testis Cancer | Testicular Cancer | Germ Cell Tumor | Testicular Yolk Sac Tumor | Testicular Choriocarcinoma | Germ Cell Tumor of Testis | Germ Cell Tumor, Testicular, Childhood | Germ Cell Cancer Metastatic | Germ Cell Neoplasm of Retroperitoneum and other conditionsUnited States
-
Indiana UniversityActive, not recruitingTesticular CancerUnited States
-
Centre Leon BerardNational Cancer Institute, FranceRecruitingMetastatic Testicular CancerFrance
Clinical Trials on Education brochure
-
Hospital Israelita Albert EinsteinUnknownEducation of PatientsBrazil
-
Pamukkale UniversityCompleted
-
University of California, San FranciscoCompleted
-
Saglik Bilimleri UniversitesiNot yet recruitingAsthma | Patient EmpowermentTurkey
-
Seoul National University HospitalUnknownSuspicious for Pulmonary TuberculosisKorea, Republic of
-
Abant Izzet Baysal UniversityThe Scientific and Technological Research Council of TurkeyCompletedPhysical Therapy | Student | Education, Competency-BasedTurkey (Türkiye)
-
Yeditepe UniversityActive, not recruitingHealth Knowledge,Practices,Attitudes | Vulva Disease | Vulvar Self-ExaminationTurkey (Türkiye)
-
University of British ColumbiaTerminated
-
Norwegian University of Science and TechnologyKathmandu University School of Medical SciencesCompleted
-
Saglik Bilimleri UniversitesiCompletedUrologic Diseases | UrodynamicsTurkey